Skip Navigation

Cardiovascular Research 1997 35(3):480-489; doi:10.1016/S0008-6363(97)00167-3
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Melillo, G.
Right arrow Articles by Capogrossi, M. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melillo, G.
Right arrow Articles by Capogrossi, M. C
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Gene therapy for collateral vessel development

Guido Melilloa, Marco Scocciantia, Imre Kovesdib, Jorge Safi, Jrc, Teresa Riccionia,c and Maurizio C Capogrossia,c,*

aLaboratorio di Patologia Vascolare, Istituto Dermopatico dell'Immacolata, Via dei Monti di Creta 104, 00167 Rome, Italy
bGenVec Inc., Rockville, MD, USA
cGene Therapy Unit, Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA

* Corresponding author. Tel.: +39 6 66467106; Fax: +39 6 66462430; e-mail: capogrossi@idi.it

Transfer of the cDNA coding for angiogenic factors represents a novel and promising approach to induce therapeutic angiogenesis and enhance blood flow to ischemic tissues which cannot be revascularized otherwise. This review will focus on therapeutic angiogenesis based on gene transfer techniques for the treatment of myocardial and limb ischemia. The experimental studies demonstrating the angiogenic effect of recombinant growth factors in animal models and in humans, as well as the most promising methods for gene transfer, will be described. Further, gene transfer studies to induce therapeutic angiogenesis will be reviewed to identify critical questions that still need to be answered before gene therapy with angiogenic factors may be considered for routine clinical application.

KEYWORDS Gene therapy; Angiogenesis; Ischemia; FGF; VEGF; Heparin; Adenovirus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Parenti, L. Bellik, L. Brogelli, S. Filippi, and F. Ledda
Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1978 - H1984.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
V. Lambert, R. Michel, G.-M. Mazmanian, E. M. Dulmet, A. Capderou, P. Herve, C. Planche, and A. Serraf
Induction of pulmonary angiogenesis by adenoviral-mediated gene transfer of vascular endothelial growth factor
Ann. Thorac. Surg., February 1, 2004; 77(2): 458 - 463.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Parenti, L. Brogelli, S. Filippi, S. Donnini, and F. Ledda
Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1
Cardiovasc Res, July 1, 2002; 55(1): 201 - 212.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. M. Asperio, E. Nicolato, P. Marzola, P. Farace, E. Lunati, A. Sbarbati, and F. Osculati
Delayed Muscle Injuries in Arterial Insufficiency: Contrast-enhanced MR Imaging and
Radiology, August 1, 2001; 220(2): 413 - 419.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. J. Post, R. Laham, F. W. Sellke, and M. Simons
Therapeutic angiogenesis in cardiology using protein formulations
Cardiovasc Res, February 16, 2001; 49(3): 522 - 531.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. R. Schwarz, M. T. Speakman, M. Patterson, S. S. Hale, J. M. Isner, L. H. Kedes, and R. A. Kloner
Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1323 - 1330.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens
Gene therapy in the cardiovascular system: an update
Cardiovasc Res, December 1, 1999; 44(3): 498 - 506.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. G. Favaloro
Landmarks in the Development of Coronary Artery Bypass Surgery
Circulation, August 4, 1998; 98(5): 466 - 478.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.